Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MSA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05310864
What this trial is testing

Comparison of the Distance Between the Femoral Artery and Veins in Various Position in Malay Race Adult

Who this might be right for
Femoral Artery and Vein DistanceAnatomic
Aldy Heriwardito 50
Not applicableStudy completedNCT06469684
What this trial is testing

A Health Education Intervention Tailored for Malay-Muslim Women

Who this might be right for
Breast Cancer
National University of Singapore 66
Not applicableActive Not RecruitingNCT05792332
What this trial is testing

Integrated Management of Atypical Parkinsonism: A Home-based Patient-Centered Healthcare Delivery Based on Telenursing (IMPACT Study)

Who this might be right for
Atypical ParkinsonismMSA - Multiple System AtrophyPSP+2 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 164
Not applicableUnknownNCT04313530
What this trial is testing

TMS Treatment in Multiple System Atrophy With Fatigue

Who this might be right for
Transcranial Magnetic StimulationMultiple System AtrophyFatigue
Xuanwu Hospital, Beijing 22
Large-scale testing (Phase 3)Active Not RecruitingNCT05696717
What this trial is testing

Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy

Who this might be right for
Symptomatic Neurogenic Orthostatic HypotensionMSA - Multiple System Atrophy
Theravance Biopharma 102
Not applicableStudy completedNCT00095589
What this trial is testing

Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer

Who this might be right for
Bladder Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 125
Testing effectiveness (Phase 2)UnknownNCT00758849
What this trial is testing

Fipamezole in Neurogenic Orthostatic Hypotension

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Parkinson's DiseaseMultiple System Atrophy
Juvantia Pharma Ltd 24
Early research (Phase 1)Active Not RecruitingNCT05698017
What this trial is testing

Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early to Moderate Stage Multiple System Atrophy (MSA)

Who this might be right for
Multiple System AtrophyMSA - Multiple System Atrophy
Cytora Ltd. 10
Testing effectiveness (Phase 2)Study completedNCT00800839
What this trial is testing

Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide

Who this might be right for
Hematologic DiseasesLeukemiaLymphoma+1 more
M.D. Anderson Cancer Center 56
Very early researchLooking for participantsNCT07640542
What this trial is testing

Test-retest Trial With [11C]MODAG-005 in PD or MSA and AMHC - Pilot Phase

Who this might be right for
Parkinson Disease (PD)MSA - Multiple System AtrophyHealthy Adult Participants
MODAG GmbH 9
Large-scale testing (Phase 3)Looking for participantsNCT07446894
What this trial is testing

MSA-01 in Multiple System Atrophy

Who this might be right for
Multiple System Atrophy (MSA)
Tokyo University 140
Large-scale testing (Phase 3)Study completedNCT00633880
What this trial is testing

Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Non-diabetic NeuropathyPrimary Autonomic Failure+1 more
Chelsea Therapeutics 181
Not applicableLooking for participantsNCT06236789
What this trial is testing

Observation Study to Evaluate the Efficacy and Safety of Ifosfamide/Mesna in Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasm
Yonsei University 60
Not applicableLooking for participantsNCT02795052
What this trial is testing

Neurologic Stem Cell Treatment Study

Who this might be right for
Neurologic DisordersNervous System DiseasesNeurodegenerative Diseases+23 more
MD Stem Cells 500
Large-scale testing (Phase 3)Ended earlyNCT04095793
What this trial is testing

Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
Theravance Biopharma 110
Testing effectiveness (Phase 2)Study completedNCT00524199
What this trial is testing

Effects of Mesna on Homocysteine in Kidney Failure

Who this might be right for
End Stage Renal Disease
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 10
Testing effectiveness (Phase 2)Ended earlyNCT00941928
What this trial is testing

Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
LeukemiaPediatric Cancer
M.D. Anderson Cancer Center 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT05923866
What this trial is testing

ONO-2808 in Patients With Multiple System Atrophy

Who this might be right for
Multiple System Atrophy (MSA)
Ono Pharmaceutical Co., Ltd. 92
Not applicableStudy completedNCT05819957
What this trial is testing

Therapeutic Education for Multiple System Atrophy (MSA) Patients and Their Caregivers

Who this might be right for
Multiple System Atrophy
University Hospital, Toulouse 15
Testing effectiveness (Phase 2)Study completedNCT00857389
What this trial is testing

Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies

Who this might be right for
Stem Cell TransplantationLeukemiaLymphoma
M.D. Anderson Cancer Center 60
Next Page